Mobile Site ›
Print Friendly View

Test ID: PCPRO    
Plasma Cell DNA Content and Proliferation, Bone Marrow

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Useful For Suggests clinical disorders or settings where the test may be helpful

Establishing a diagnosis of a plasma cell proliferative disorder

 

Providing prognostic information for newly diagnosed multiple myeloma and other plasma cell proliferative disorders

 

Assessing response to therapy and detecting disease relapse and progression in treated plasma cell proliferative disorder patients

 

Determining plasma cell DNA content and proliferation

Additional Tests Lists test(s) that are always performed, at an additional charge, with the initial test(s)

Test IDReporting NameAvailable SeparatelyAlways Performed
88465Flow Cytometry Interp, 2-8 MarkersNo, (Bill Only)Yes

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

See Laboratory Screening Tests for Suspected Multiple Myeloma in Special Instructions.

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Flow Cytometry/DNA Content/Cell Cycle Analysis

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

Plasma Cell Proliferation, Marrow

Aliases Lists additional common names for a test, as an aid in searching

PC Proliferation
Myeloma Staging
Plasma Cell Staging
Labeling Index
PCLIP
Plasma Cell Labeling Index (PCLI)